200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 75738-58-8

75738-58-8

75738-58-8 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,hydrochloride(2:1),(6R,7R)-

CAS No: 75738-58-8 Catalog No: AG0039LQ MDL No:MFCD01750403

Product Description

Catalog Number:
AG0039LQ
Chemical Name:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,hydrochloride(2:1),(6R,7R)-
CAS Number:
75738-58-8
Molecular Formula:
C16H18ClN9O5S3
Molecular Weight:
548.0194
MDL Number:
MFCD01750403
IUPAC Name:
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride
InChI:
InChI=1S/2C16H17N9O5S3.ClH/c2*1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7;/h2*5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29);1H/b2*21-8-;/t2*9-,13-;/m11./s1
InChI Key:
MPTNDTIREFCQLK-UNVJPQNDSA-N
SMILES:
CO/N=C(\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)CSc1nnnn1C)/c1csc(n1)N.Cl
EC Number:
278-299-4
UNII:
NON736D32W

Properties

Complexity:
890  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
4  
Defined Bond Stereocenter Count:
2  
Exact Mass:
1058.08g/mol
Formal Charge:
0
Heavy Atom Count:
67  
Hydrogen Bond Acceptor Count:
28  
Hydrogen Bond Donor Count:
7  
Isotope Atom Count:
0
Molecular Weight:
1059.558g/mol
Monoisotopic Mass:
1058.08g/mol
Rotatable Bond Count:
16  
Topological Polar Surface Area:
539A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Biocontrol science 20120601
[Drug sensitivity of causative agents in ocular infection of external adnexa and anterior segments--multicenter study of causative agents and drug sensitivity of ocular infection by the Japanese Association for Ocular Infection part II]. Nippon Ganka Gakkai zasshi 20110901
Acute encephalopathy in a child with secondary carnitine deficiency due to pivalate-conjugated antibiotics. The Pediatric infectious disease journal 20110101
[Evaluation of antimicrobial prophylaxis after normal delivery]. The Japanese journal of antibiotics 20090401
Pharmacokinetics and bioequivalence studies of cefteram pivoxil in healthy Chinese volunteers. European journal of drug metabolism and pharmacokinetics 20090101
Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers. Clinical therapeutics 20080401
Ceftezole, a cephem antibiotic, is an alpha-glucosidase inhibitor with in vivo anti-diabetic activity. International journal of molecular medicine 20070901
In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801
[The effect of preoperative topical antibiotics in cataract surgery]. Nippon Ganka Gakkai zasshi 20060701
Characteristics of Pseudomonas corneal infection related to orthokeratology. Cornea 20051001
Hepatic natural killer and natural killer T cells markedly decreased in two cases of drug-induced fulminant hepatic failure rescued by living donor liver transplantation. Journal of gastroenterology and hepatology 20050701
[Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004]. The Japanese journal of antibiotics 20041201
Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method. The Journal of international medical research 20040101
Heterogeneity of IgE response to cefteram pivoxil was noted in 2 patients with cefteram-induced occupational asthma. The Journal of allergy and clinical immunology 20030701
[Antibiotic ophthalmic solutions evaluated by pharmacokinetic parameters of maximum concentration in the aqueous]. Nippon Ganka Gakkai zasshi 20020401
Effects of the quantity of water and milk ingested concomitantly with AS-924, a novel ester-type cephem antibiotic, on its pharmacokinetics. International journal of antimicrobial agents 20011101
Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic--comparison with cefteram-pivoxil. International journal of antimicrobial agents 20011101
Evaluation of oral antimicrobial agent levels in tooth extraction sites. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010601
[Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis]. The Japanese journal of antibiotics 19950501
Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia. The Annals of pharmacotherapy 19940301
Cefmenoxime in corneal organ culture. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 19940101
Therapeutic efficacy of chloramphenicol, co-trimoxazole (trimethoprim/sulphamethoxazole), cefmenoxime and ceftriaxone in experimental bacteraemia and meningitis caused by ampicillin-resistant Haemophilus influenzae type b. The Journal of antimicrobial chemotherapy 19881101
Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrobial agents and chemotherapy 19810101

© 2019 Angene International Limited. All rights Reserved.